Glioblastoma Multiforme Treatment Market Analysis By Treatment (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Other Treatments), By Drug Class (Temozolomide, Lomustine, Bevacizumab, Other Drug Classes), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Oct 2024
- Report ID: 49807
- Number of Pages: 372
- Format:
-
-
-
- F. Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Merck & Co.Inc.
- Amneal Pharmaceuticals
- Arbor Pharmaceuticals LLC
- Pfizer Inc Company Profile
- Amgen Inc.
- Boston Biomedical Inc.
- Sun Pharmaceutical Industries Ltd.
- Karyopharm Therapeutics Inc.
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible